Skip to main content
Log in

Metformin-associated lactic acidosis in Sweden 1977–1991

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Since the withdrawal of phenformin in 1978, the use of metformin has increased from 13,500 to 22,00 patient years/year. During the period 1977–91 a total of 18 cases of metformin — associated acidosis was reported, of which 16 had lactic acidosis.

The incidence of reported acidosis and lactic acidosis decreased from 1.50 cases per 10,000 patient years in 1977–81 to 0.24 cases per 10,000 patient years 1987–91, probably due to lower doses doses and reduced usage in the very old. All the reports described patients with several other concomitant diseases, mainly cardiovascular and renal, when the acidosis was diagnosed.

It is important continuously to re-evaluate metformin therapy and to stop treatment at the onset of impaired renal or cardiovascular function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hermann LS, melander A (1992) Biguanides: basic aspects and clinical uses. In: Alberti KGMM, DeFronzo RA, Keen H, Zimmet P (eds) Textbook of Diabetes Mellitus. Wiley, New York Chichester, pp 773–795

    Google Scholar 

  2. Vigneri R, Goldfine I (1987) Role of metformin in treatment of diabetes mellitus. Diabetes Care 10: 118–122

    PubMed  CAS  Google Scholar 

  3. Bergman U, Boman G, Wiholm B-E (1978) Epidemiology of adverse drug reactions to phenformin and metformin. BMJ 2: 464–466

    PubMed  CAS  Google Scholar 

  4. Wiholm B-E (1983) Spontaneous reporting of ADR. Fertilization with register data on morbidity and drug utilization. In: Skandia International Symposia, Stockholm

  5. Myrhed M (1989) Drug induced morbidity. The size of the problem and possible strategies for intervention. Symposium arranged by the Swedish Drug Insurance Association, Stockholm

  6. Nordic Statistics of Medicines 1975–1977 (1979) Part I. Nordic Council on Medicines, Uppsala

  7. Svensk Läkemedelsstatistik (1988) Apoteksbolaget, Stockholm

  8. Karam JH, Matin SB, Forsham PH (1975) Antidiabetic drugs after the University Group Diabetes Program (UGDP). Ann Rev Pharmacol 15: 351–366

    Article  PubMed  CAS  Google Scholar 

  9. Czyzyk A, Tawecki J, Sadowski J, Ponikowska I, Szczepanik Z (1986) Effect of biguanides on intestinal absorption of glucose. Diabetes 17: 492–498

    Google Scholar 

  10. Searle GL, Gulli R (1980) The mechanism of the acute hypoglycemic action of phenformin (DMI). Metabolism 29: 630–635

    Article  PubMed  CAS  Google Scholar 

  11. Hermann LS (1973) Biguanides and lactate metabolism: a review. Dan Med Bull 20: 65–79

    PubMed  CAS  Google Scholar 

  12. Luft D, Schmulling RM, Eggstein M (1978) Lactic acidosis in biguanide-treated diabetics. Diabetologia 14: 75–87

    Article  PubMed  CAS  Google Scholar 

  13. Shah RR, Oates NS, Idle JR, Smith RL (1980) Genetic impairment of phenformin metabolism. Lancet II: 1147

    Article  Google Scholar 

  14. Wiholm B-E, Alván G, Bertilsson L, Säwe J, Sjöqvist F (1981) Hydroxylation of debrisoquine in patients with lactic acidosis after phenformin. Lancet I: 1099

    Google Scholar 

  15. Campbell IW (1984) Metformin and glibenclamide comparative risks. BMJ 289: 289

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wiholm, B.E., Myrhed, M. Metformin-associated lactic acidosis in Sweden 1977–1991. Eur J Clin Pharmacol 44, 589–591 (1993). https://doi.org/10.1007/BF02440866

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02440866

Key words

Navigation